Cargando…

A Comprehensive and Bias-Free Machine Learning Approach for Risk Prediction of Preeclampsia with Severe Features in a Nulliparous Study Cohort

OBJECTIVE: Preeclampsia is one of the leading causes of maternal morbidity, with consequences during and after pregnancy. Because of its diverse clinical presentation, preeclampsia is an adverse pregnancy outcome that is uniquely challenging to predict and manage. In this paper, we developed machine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yun, MALLIA, Daniel, CLARK-SEVILLA, Andrea, CATTO, Adam, LESHCHENKO, Alisa, YAN, Qi, Haas, David, WAPNER, Ronald, PE'ER, Itsik, RAJA, Anita, SALLEB-AOUISSI, Ansaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120773/
https://www.ncbi.nlm.nih.gov/pubmed/37090627
http://dx.doi.org/10.21203/rs.3.rs-2635419/v1
Descripción
Sumario:OBJECTIVE: Preeclampsia is one of the leading causes of maternal morbidity, with consequences during and after pregnancy. Because of its diverse clinical presentation, preeclampsia is an adverse pregnancy outcome that is uniquely challenging to predict and manage. In this paper, we developed machine learning models that predict the onset of preeclampsia with severe features or eclampsia at discrete time points in a nulliparous pregnant study cohort. MATERIALS AND METHODS: The prospective study cohort to which we applied machine learning is the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be (nuMoM2b) study, which contains information from eight clinical sites across the US. Maternal serum samples were collected for 1,857 individuals between the first and second trimesters. These patients with serum samples collected are selected as the final cohort. RESULTS: Our prediction models achieved an AUROC of 0.72 (95% CI, 0.69–0.76), 0.75 (95% CI, 0.71–0.79), and 0.77 (95% CI, 0.74–0.80), respectively, for the three visits. Our initial models were biased toward non-Hispanic black participants with a high predictive equality ratio of 1.31. We corrected this bias and reduced this ratio to 1.14. The top features stress the importance of using several tests, particularly for biomarkers and ultrasound measurements. Placental analytes were strong predictors for screening for the early onset of preeclampsia with severe features in the first two trimesters. CONCLUSION: Experiments suggest that it is possible to create racial bias-free early screening models to predict the patients at risk of developing preeclampsia with severe features or eclampsia nulliparous pregnant study cohort.